← All indications
Bone Diseases, Metabolic
Diseases that affect the METABOLIC PROCESSES of BONE TISSUE.
Subtype terms (5)
More specific conditions that are subtypes of Bone Diseases, Metabolic in the MeSH hierarchy.
- Bone Demineralization, Pathologic
- Mucolipidoses
7 drugs (6 approved, 1 experimental)
- Osteoporosis
238 drugs (121 approved, 117 experimental)
- Pseudohypoparathyroidism
3 drugs approved
- Rickets
6 drugs (4 approved, 2 experimental)
Drugs by status
Approved for this indication (1)
Phase 4 trials (35)
- vitamin d3
- denosumab
- tibolone
- alfacalcidol
- calcium carbonate
- raloxifene
- evogliptin
- valproic acid
- eldecalcitol
- gliclazide
- tenofovir
- calcium
- lactulose
- ritonavir
- carbamazepine
- topiramate
- lanthanum
- pamidronate
- atazanavir
- alendronic acid
- potassium citrate
- sofosbuvir
- strontium ranelate
- emtricitabine
- calcitriol
- velpatasvir
- vildagliptin
- zoledronic acid
- bictegravir
- dapagliflozin
- +5 more
Phase 3 trials (14)
Phase 2 trials (17)
Phase 1 trials (10)
Organizations
Organization Involved with Phase 4 Indications (42)
- Roche
- Gilead Sciences
- Merck
- Sanofi
- Novartis
- Bayer
- Solvay
- National Institute of Mental Health (NIMH)
- Cornell University
- Harvard University
- Danderyds Hospital
- McGill University
- McMaster University
- Monash University
- Osaka University
- Seoul National University
- Stanley Dudrick's Memorial Hospital
- University Hospital of North Norway
- University of Milan
- Laval University
- University of Calgary
- University of California, San Francisco
- University of Vienna
- The Alfred Hospital
- Centro de Diabetes Curitiba
- University of Turin
- University of Barcelona
- University of Northern Norway
- University of Wisconsin
- Humboldt University
- +12 more
Organization Involved with Phase 3 Indications (29)
- Amgen
- Novo Nordisk
- Duramed Research
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Warner Chilcott
- Ain Shams University
- Glaser Pediatric Research Network
- St. Joseph Hospital Health Center
- University of Medicine and Dentistry of New Jersey
- University of Messina
- University of Miami
- University of Nebraska
- University of Tehran
- University of Toronto
- Chonbuk National University
- Columbia University
- Creighton University
- Kwong Wah Hospital
- University of Lyon
- CHU Mont-Godinne
- University of Paris
- Canadian Institutes of Health Research (CIHR)
- Crohn's and Colitis Foundation
- Elizabeth Glaser Pediatric AIDS Foundation
- Government of France
- Nestle
- University Clermont Auvergne
- Nahda University
Organization Involved with Phase 2 Indications (33)
- Genentech
- Perrigo
- Atlantia Food Clinical Trials
- Azelon Pharmaceuticals
- BioGaia AB
- DSM
- Endo Pharmaceuticals
- mdRNA
- Probi AB
- Sponsor GmbH
- Tarsa Therapeutics, Inc.
- National Cancer Institute (NCI)
- National Institute of Allergy and Infectious Diseases (NIAID)
- Baylor University
- Emory University
- Northwestern University
- Stanford University
- Tufts University
- University of Strathclyde
- University of Zurich
- Taipei Medical University
- Tel Aviv University
- University of California, San Diego
- University of Chicago
- University of Cincinnati
- University of Minnesota
- BioActor
- Medical University of Vienna
- University of Gothenburg
- State University of New York, Buffalo
- +3 more
Organization Involved with Phase 1 Indications (9)
Organization Involved with Other Experimental Indications (43)
- Shire
- Lesieur
- Taiwan Biotech Co., Ltd.
- Genovate Biotechnology Co., Ltd.,
- National Institutes of Health (NIH)
- National Research Center for Preventive Medicine
- Central South University
- Appalachian State University
- Cairo University
- DLR German Aerospace Center
- Florida State University
- Georgetown University
- Medical University of Warsaw
- Shanghai University of Traditional Chinese Medicine
- University of New Mexico
- University of Thessaly
- University of Athens
- University of Bologna
- Mayo Clinic
- State University of New York
- University of Copenhagen
- University of Trieste
- Princess Anna Mazowiecka Hospital
- Biofortis
- Government of China
- German Aerospace Centre
- University of Sao Paulo
- Integrative Health Technologies
- State University of New York, Syracuse
- European Commission
- +13 more